ABIOMED Inc (ABMD)

traders view logo Charts by TradingView

Pricing is indicative. Past performance is not a reliable indicator of future results. Log in to see latest markets data.

ABIOMED Inc (ABMD) Profile

ABIOMED Inc (ABMD.xnas) is a publicly-traded medical devices cοmpany headquartered in Danvers, Massachusetts, America. The company develοps manufactures, and market prοducts tο allοw the heart tο rest, heal, and recοver by bettering blοοd flοw οr perfοrming the heart’s pumping functiοn. Abiοmed’s prοducts are used by interventiοnal cardiοlοgists and heart surgeοns fοr patients whο need hemοdynamic suppοrt during οr after angioplasty or heart surgery procedures. Abiomed, Inc. offers its products in the United States, Europe, Japan, Canada, the Asia-Pacific, Latin America, and the Middle East. The company has three offices out of Danvers, in Berlin and Aachen (Germany), one in Tokyo (Japan), and employs 1,536 people. The Abiomed stock (ABMD.xnas) is listed on the NASDAQ, had a market capitalisation of $15.31B (USD) as of January 2022 and an $840.9M (USD) in 2020 yearly revenue. In late 2019, the company had five FDA approvals and 715 patents with 622 pending. In the middle of 2021, Abiomed’s Impella ECP, the world's smallest heart pump, was granted the designation by the FDA and established its strict requirements. Impella ECP’s size may help more physicians to offer critical hemodynamic support to coronary artery disease patients who require it.

Holding cost
Long
-5%
Short
-2.5%
Trading hours in US Eastern Time
Fri
16:30-23:00
Mon
16:30-23:00
Tue
16:30-23:00
Wed
16:30-23:00
Thu
16:30-23:00
Sun
Closed
Sat
Closed

Share CFD Trading FAQ

Each investor owning shares of a company is also owning fragments of the company. A quite simple way to explain what a stock is is basically when a company divides itself into several shares and then it makes a part of these equities available to the public, at a price. Each investor owning shares of a company is owning fragments of the company.

While shares represent units of ownership within a company Contracts for Difference (CFDs) allow traders to speculate on the future share price fluctuations of an underlying asset. Thus when trading CFDs traders do not physically own the underlying asset. CFDs are available for a range of underlying assets, such as shares, commodities, and foreign exchange, and indices.

Why Trade ABIOMED Inc (ABMD.xnas) with FP Markets? An Australian-regulated forex & CFD broker
go long or short
Go Long or Short

Increase your ability to profit in
all market conditions
Leverage options up to 20:1

direct market access
Direct Market Access (DMA) Execution

Real-time, transparent share prices
Control, Functionality and deep liquidity
Full Market depth & see your orders in the queue

advanced platforms
Advanced Platforms
& Technology

MT4, MT5, Webtrader & Iress with
superior client portal

24/5 Multilingual customer support
24/5 Multilingual
Customer Support

Award winning support &
personal account managers

global exposure
Global Exposure

Low margins and competitive commission
+10,000 products on global stocks
across 4 continents

earn dividends
Earn Dividends

On long positions
No ownership of physical
shares necessary

규제된 호주 브로커의 지원을 받아 거래를 시작하세요

bullet10,000여 금융상품 거래 가능
bullet자동으로 포지션 개시 및 종료
bullet뉴스 및 경제 캘린더
bullet보조지표 및 차트
bullet기타 여러 도구 포함

고객님께서 이메일을 제공해주신다는 것은 FP Markets 개인 정보 정책에 동의함과 동시에 마케팅자료를 받아 보신다는 것을 의미합니다. 언제든지 구독취소가 가능합니다.




Source - cache | Page ID - 13719

Get instant Updates in Telegram